title: [Response to comment on the article "DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico" by Enrique Bolado-Martínez and collaborators].
authors.forename: Enrique
authors.initials: E
authors.lastname: Bolado-Martínez
authors.forename: Anxis
authors.initials: A
authors.lastname: Pérez-Mendoza
authors.forename: Francisco Monserrat
authors.initials: FM
authors.lastname: Alegría-Morquecho
authors.forename: María del Carmen
authors.initials: Mdel C
authors.lastname: Candia-Plata
authors.forename: María del Rosario
authors.initials: Mdel R
authors.lastname: Aguayo-Verdugo
authors.forename: Gerardo
authors.initials: G
authors.lastname: Alvarez-Hernández
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000235:genetics*; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D009154:Mutation; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics*; D012293:Rifampin / Q000494:pharmacology*
chemical_list: D000995:Antitubercular Agents; D004269:DNA, Bacterial; D007538:Isoniazid; D012293:Rifampin